If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

They included patients with native aortic valve sclerosis or nonsevere AS ... arms shared comparable baseline AS severity (66% sclerosis, 23% mild stenosis, 11% moderate stenosis).

Researchers have found in a new study that SGLT2 inhibitors may have disease-modifying effects in nonsevere aortic stenosis ...

used retrospective electronic medical record data from the Yale New Haven Health System from January 2016 to September 2022 to follow 11,698 patients with native aortic valve sclerosis (66%) or ...

Endothelial disruption, sclerosis and calcification, all predominantly affect the aortic side of the valve at the leaflet bases where it ... The largest SEAS trial randomised 1873 patients with ...

She had a history of SLE and systemic sclerosis for eight years and ... ejection fraction was 45%, there was mild mitral regurgitation, pulmonary artery pressure was 30 mmHg, and aortic valve cusps ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

Background: There are insufficient data regarding how to deal with moderate aortic valve (AV) dysfunction during rheumatic mitral valve (MV) surgery. In this study, the clinical outcomes of patients ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...